JNJ met main goal in late-stage trial for ulcerative colitis treatment
Johnson & Johnson (JNJ) said on Friday that its late-stage study of TREMFYA as an induction therapy for adults with ...
TMCnet7h
Iterative Health to Present AI Advancements at ECCO 2025, Highlighting Potential to Evolve Ulcerative Colitis Clinical Trial Endpoints
"There is a pressing need to modernize traditional endoscopic assessments in IBD to enhance precision and efficiency in ulcerative colitis research," said Mark Genovese, MD, Senior Vice President of ...
Medscape13h
Antibiotics Getting False Blame for Colitis, Study Finds
A nationwide study of older adults in Sweden suggests a suspected link between antibiotic use and microscopic colitis is more ...
Unfolded protein response: A key regulator of intestinal health and disease
The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and ...